GATC acquires SOLiD DNA Sequencer from Applied Biosystems


GATC Biotech announced the acquisition of a SOLiD(TM) DNA sequencing system from Applied Biosystems. The new system will be the third next generation sequencing technology to be installed in GATC's German research facility in Constance, which currently holds the GS FLX(TM) from Roche Diagnostics as well as the Genome Analyzer(TM) from Illumina.

Being a part of Applied Biosystems' Early-Access Program, the SOLiD System is expected to be installed in early autumn this year and will boost the company's current sequencing capacity from 130 gigabases to 250 gigabases a year. Therefore GATC will be the first and only commercial sequencing service provider worldwide being able to offer ultra high-throughput DNA analysis using all three leading next generation sequencing technologies. The total investment exceeds 2 million Euros.

Other news from the department business & finance

Most read news

More news from our other portals